Until September 2024, Harald Enzmann provided a monthly newsletter on the regulatory decisions of the Committee for Medicinal Products for Human Use (CHMP) on innovative medicines for the treatment of cancer. From now on, you will find this and other information in our Infothek Onkologie (in german language).

Enzmann was Chairman of the CHMP from 2018 to 2024 and heads the "EU and International Affairs" staff unit at the BfArM. The CHMP at the European Medicines Agency is made up of scientists from all member states of the EEA.

Last issue

The newsletter contextualizes the latest developments and decisions and provides links to more detailed information such as the latest EPARs. It is intended as a user-friendly, concise information platform for pharmacologists and oncologists who treat patients, work in research and development or in regulatory affairs, as well as patients and patient representatives.

Previous issues